Skip to main content
logo
Pulse Biosciences, Inc. (FRA:6L8)
Germany flag Germany · Delayed Price · Currency is EUR
12.20
+0.10 (0.83%)
At close: Jan 23, 2026

Pulse Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-74.73-53.59-42.21-58.51-63.66-49.85
Depreciation & Amortization
1.11.181.211.361.151.1
Loss (Gain) From Sale of Assets
0.010.010.010.19-0.12
Loss (Gain) From Sale of Investments
----0.01-0
Stock-Based Compensation
23.2813.597.185.1914.610.08
Other Operating Activities
---8.48--
Change in Accounts Receivable
-0.02--0.06-0.06-
Change in Inventory
-0.06---2.65-5.82-
Change in Accounts Payable
1.31-0.20.26-1.31.16-0.27
Change in Unearned Revenue
----0.020.02-
Change in Other Net Operating Assets
0.62.670.510.2-1.493.47
Operating Cash Flow
-48.51-36.34-33.04-47.01-54.1-35.37
Capital Expenditures
-0.26-0.13-0.12-0.4-0.44-0.44
Investment in Securities
----810.49
Investing Cash Flow
-0.28-0.13-0.12-0.47.5610.04
Short-Term Debt Issued
----1.94-
Long-Term Debt Issued
---65--
Total Debt Issued
---651.94-
Short-Term Debt Repaid
----0.44-1.53-
Total Debt Repaid
----0.44-1.53-
Net Debt Issued (Repaid)
---64.560.41-
Issuance of Common Stock
65.03110.4216.3915.3862.5130.89
Repurchase of Common Stock
-----0.23-
Other Financing Activities
-0.06-0.28-0.01---
Financing Cash Flow
64.98110.1416.3979.9462.6930.89
Net Cash Flow
16.1873.67-16.7732.5316.155.56
Free Cash Flow
-48.77-36.47-33.16-47.41-54.53-35.81
Free Cash Flow Margin
-56713.95%---6773.43%-3845.84%-
Free Cash Flow Per Share
-0.74-0.62-0.67-1.40-1.95-1.54
Cash Interest Paid
--1.7---
Levered Free Cash Flow
-23.17-17.92-18.13-26.84-30.4-18.77
Unlevered Free Cash Flow
-23.17-17.92-17.44-26.27-29.96-18.77
Change in Working Capital
1.842.470.77-3.72-6.23.2
Source: S&P Global Market Intelligence. Standard template. Financial Sources.